000 | 01590 a2200481 4500 | ||
---|---|---|---|
005 | 20250513132109.0 | ||
264 | 0 | _c19980130 | |
008 | 199801s 0 0 eng d | ||
022 | _a0022-2275 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGrainger, D J | |
245 | 0 | 0 |
_aTransforming growth factor beta is sequestered into an inactive pool by lipoproteins. _h[electronic resource] |
260 |
_bJournal of lipid research _cNov 1997 |
||
300 |
_a2344-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCholesterol, LDL |
650 | 0 | 4 | _aChromatography, Gel |
650 | 0 | 4 |
_aChylomicrons _xblood |
650 | 0 | 4 |
_aDiabetes Mellitus _xmetabolism |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLipoproteins _xblood |
650 | 0 | 4 |
_aLipoproteins, HDL _xblood |
650 | 0 | 4 |
_aLipoproteins, LDL _xblood |
650 | 0 | 4 |
_aLipoproteins, VLDL _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMink |
650 | 0 | 4 | _aProtein Serine-Threonine Kinases |
650 | 0 | 4 | _aReceptor, Transforming Growth Factor-beta Type II |
650 | 0 | 4 |
_aReceptors, Transforming Growth Factor beta _xmetabolism |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
650 | 0 | 4 |
_aTransforming Growth Factor beta _xblood |
700 | 1 | _aByrne, C D | |
700 | 1 | _aWitchell, C M | |
700 | 1 | _aMetcalfe, J C | |
773 | 0 |
_tJournal of lipid research _gvol. 38 _gno. 11 _gp. 2344-52 |
|
999 |
_c9362186 _d9362186 |